Inhaled Interferons to treat COVID-19
Why interferons? SARS CoV viruses block interferon production in infected cells, allowing the virus to continue replicating unabated. Treatment with interferons
Tag: Covid-19
Wacker on cyclodextrins in the COVID fight
The world’s largest cyclodextrin producer, Wacker Chemie has recently published a press release on cyclodextrins and their role in the
CD‐sACE2 complexes against Covid-19
Cyclodextrin‐soluble angiotensin‐converting enzyme 2 (CD‐sACE2) inclusion compounds can be useful in the treatment of SARS‐CoV‐2 infections by blocking S‐proteins .
Australia’s TGA approves remdesivir while Gilead reports reduced mortality risk
The Therapeutic Goods Administration (TGA) of Australia has awarded provisional approval for the use of Gilead Sciences’ remdesivir (Veklury) to
Cyclodextrins in first-line defense against COVID-19
Medical press published the news on the research at the University of Southern California (USC) Dr. Allen and Charlotte Ginsburg
Repurpusing Famotidine against COVID-19: a Hope or a Hype?
Clinicians and scientists have been studying a number of old existing drugs with the hope of finding therapies they can
Gilead prices remdesivir at 390$/vial for governments
Daniel O’Day, Chairman & CEO, Gilead Sciences posted an open letter yesterday, to share pricing indications for Gilead anti-COVID19 treatment,
Summary of currently available drugs which can be potentially used for treatment of COVID-19
The Table below was published in e-book International Pulmonologist’s Consensus On Covid-19 2nd ed 2020 on April 22nd 2020 (ed. Tinku
Gilead to Test a Version of Remdesivir That Can Be Inhaled
The New York Times published on June 22, 2020: The American biopharmaceutical company Gilead Sciences will soon start trials of
A new country to approve remdesivir for COVID-19 treatment: Israel
Israel approved on Tuesday the use of Gilead Sciences Inc’s antiviral drug remdesivir for the treatment of patients with COVID-19